Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy

Checkpoint blockade immunotherapy established a new paradigm in cancer treatment: for certain patients curative treatment requires immune reinvigoration. Despite this monumental advance, only 20%–30% of patients achieve an objective response to standard of care immunotherapy, necessitating the consi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuckran, Christopher A, Liu, Chang, Bruno, Tullia C, Workman, Creg J, Vignali, Dario AA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368550/
https://www.ncbi.nlm.nih.gov/pubmed/32675311
http://dx.doi.org/10.1136/jitc-2020-000967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368550/
https://www.ncbi.nlm.nih.gov/pubmed/32675311
http://dx.doi.org/10.1136/jitc-2020-000967

Ejemplares similares